Hydroxychloroquine and Trospium / Xanomeline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Hydroxychloroquine
Trospium / Xanomeline
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed hydroxychloroquine (Plaquenil) along with Cobenfy (which contains xanomeline and trospium). Both of these medicines can, on their own, slightly lower the point at which your brain might have a seizure. When taken together, that effect may add up, which could raise the chance of a seizure a little.
I want to be clear: this concern is theoretical, meaning it's based on how the drugs work rather than lots of real-world reports. Most people take medicines like these without a problem. Your care team can manage this safely, so keep taking both as prescribed and let your doctor or pharmacist know if you have any history of seizures.
Effect: Additive lowering of the seizure threshold, theoretically increasing seizure risk when hydroxychloroquine is combined with Cobenfy (xanomeline/trospium).
Mechanism: Pharmacodynamic (additive), not pharmacokinetic. Neither agent is enzyme-driven here; the concern is CNS excitability. Xanomeline is a muscarinic agonist with central activity; hydroxychloroquine has documented pro-convulsant potential.
- Direction: Increased seizure risk (additive PD effect).
- Severity: Major. Evidence: Theoretical. Onset: Unspecified.
- Management: Assess seizure history and other threshold-lowering agents; monitor for CNS symptoms. Individualize therapy and consider closer follow-up in at-risk patients.
What happens
An increased risk of seizures
Interaction Deep Dive
Giving hydroxychloroquine together with agents that lower the seizure threshold may heighten the risk of seizure1.
Why it happens (mechanism)
Additive lowering the seizure threshold
How to manage this interaction
Here's how a care team typically handles this combination:
- Keep taking both medicines as prescribed unless your doctor tells you otherwise.
- Your team may watch you more closely, especially if you have a history of seizures or take other medicines that can affect seizure risk.
- Tell your prescriber about any past seizures, head injuries, or epilepsy.
Get medical help right away if you have a seizure, unusual confusion, or muscle twitching. Ask your pharmacist to review your full medication list so any risk can be spotted and your treatment tailored to you.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Hydroxychloroquine and Trospium / Xanomeline together?
Combining hydroxychloroquine with Cobenfy (xanomeline/trospium) may slightly add to seizure risk in theory, so take both as prescribed and tell your care team about any seizure history or new symptoms. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Hydroxychloroquine and Trospium / Xanomeline interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Hydroxychloroquine and Trospium / Xanomeline interaction managed?
Here's how a care team typically handles this combination: Keep taking both medicines as prescribed unless your doctor tells you otherwise. Your team may watch you more closely, especially if you have a history of seizures or take other medicines that can affect seizure risk. Tell your prescriber about any past seizures, head injuries, or epilepsy. Get medical help right away if you have a seizure… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Hydroxychloroquine or Trospium / Xanomeline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: SOVUNA(R) oral tablets, hydroxychloroquine sulfate oral tablets. ANI Pharmaceuticals, Inc. (per FDA), Baudette, MN, 2024. DailyMed
Keep reading about Hydroxychloroquine
Keep reading about Trospium / Xanomeline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist